Dianthus Therapeutics (DNTH) Cash & Current Investments (2017 - 2025)
Historic Cash & Current Investments for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $402.6 million.
- Dianthus Therapeutics' Cash & Current Investments rose 4321.6% to $402.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $402.6 million, marking a year-over-year increase of 4321.6%. This contributed to the annual value of $275.2 million for FY2024, which is 5844.13% up from last year.
- According to the latest figures from Q3 2025, Dianthus Therapeutics' Cash & Current Investments is $402.6 million, which was up 4321.6% from $257.4 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Cash & Current Investments ranged from a high of $402.6 million in Q3 2025 and a low of $52.9 million during Q1 2023
- For the 4-year period, Dianthus Therapeutics' Cash & Current Investments averaged around $211.1 million, with its median value being $189.9 million (2023).
- In the last 5 years, Dianthus Therapeutics' Cash & Current Investments tumbled by 6622.37% in 2023 and then surged by 61280.08% in 2024.
- Quarter analysis of 4 years shows Dianthus Therapeutics' Cash & Current Investments stood at $75.5 million in 2022, then soared by 130.12% to $173.7 million in 2023, then surged by 58.44% to $275.2 million in 2024, then soared by 46.28% to $402.6 million in 2025.
- Its last three reported values are $402.6 million in Q3 2025, $257.4 million for Q2 2025, and $263.2 million during Q1 2025.